Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Bob P. A. van de Loo"'
Autor:
Aimée E. M. J. H. Linkens, Dennis Kurstjens, N. Anne Zwietering, Vanja Milosevic, Kim P. G. M. Hurkens, Noémi van Nie, Bob P. A. van de Loo, P. Hugo M. van der Kuy, Bart Spaetgens
Publikováno v:
Drugs - Real World Outcomes, Vol 10, Iss 3, Pp 363-370 (2023)
Abstract Background Inappropriate prescribing is associated with negative patient outcomes. In hospitalized patients, the use of Clinical Decision Support Systems (CDSSs) may reduce inappropriate prescribing and thereby improve patient-related outcom
Externí odkaz:
https://doaj.org/article/8fbe27476a954e10bbd949f42f314ce5
Autor:
Aimée E. M. J. H. Linkens, Vanja Milosevic, Noémi van Nie, Anne Zwietering, Peter W. de Leeuw, Marjan van den Akker, Jos M. G. A. Schols, Silvia M. A. A. Evers, Carlota Mestres Gonzalvo, Bjorn Winkens, Bob P. A. van de Loo, Louis de Wolf, Lucretia Peeters, Monique de Ree, Bart Spaetgens, Kim P. G. M. Hurkens, Hugo M. van der Kuy
Publikováno v:
BMC Geriatrics, Vol 22, Iss 1, Pp 1-8 (2022)
Abstract Background Due to ageing of the population the incidence of multimorbidity and polypharmacy is rising. Polypharmacy is a risk factor for medication-related (re)admission and therefore places a significant burden on the healthcare system. The
Externí odkaz:
https://doaj.org/article/364365d3fdcf4bbd9acc441826dd75be
Autor:
Sah Russel, Jorie Versmissen, Wim J R Rietdijk, TZ Zuppini, AL Lubich, RB van den Berg, JL G Le Grand, FP Pieraccini, SP Pagliarino, J Liang, Jmga Schols, MK Kemogni, FN Nagele, SB Berlinghini, RC Cabuk, C van Nieuwkoop, R Mc Menamin, RG Grinta, Hjm van Kan, J Tournoy, MG Gambera, Dmk Duchek-Mann, J Hanley, Fef Hogenhuis, J Diepstraten, GC Cohet, B Maat, F Boutkourt, LA Agnoletto, Wong, Mdc Di Carlo, GS Stemer, JR Rijo, Miriam C Faes, DM Mendes, MV Veyrier, C Bufarini, J Aleman, Fv Verri, Michael G. Scott, Npk Pons-Kerjean, GR Rametta, F Sombogaard, FP Pappalardo, LR Rossi, LE Visser, FF Falcao, Kfm Keijzers, WL Hemminga, S Andreassi, RA Kranenburg, L Van der Linden, JS Soares, Mhw Kappers, N Goodfellow, MF Falcao, Hugo van der Kuy, GG Gambarelli, M Ezinga, MC Candela, L Ashfield, KH Heitzeneder, Harmke A Polinder-Bos, Melvin Lafeber, KB Blum, K Guda, CM Masini, EL Loche, Mqg Gorgas, LF Fantini, FM de Stoppelaar, NJ Fitzhugh, LM Andrews, Cgy García Yubero, Müller, Kml Crommentuijn, GC Callens, GB Boni, Jamc Verstijnen, Simon P. Mooijaart, Eric Boersma, H Bell, Ema Slob, KB Bini, DH Haider, R Moorlag, GO Oka, M Patel, CZ Zenico, Z Safipour, Glenda Fleming, Pmg Filius, IM Martignoni, PC Chessa, Hajm de Wit, DS Deben, Pgj ter Horst, Haw van Onzenoort, S Lim, Imm van Haelst, MC Canonici, EC Capone, IC Hoogendoorn-de Graaf, L Saleh, KN Nemec, TM Bosch, PM Peverini, TF Forsthuber, FM Marchesini, MM Ebbens, RT Tessari, PC Wierenga, NL Lindner, LJ Ellerbroek, A Bulsink, Ams Schimizzi, Roos S G Sablerolles, Kpgm Hurkens, BE Bosma, Pkc Janssen, Mah Huebler, FC Caruso, AM Maiworm, E Jong, Mam Vromen, RW Van Etten, M Miarons, EM Kemper, Akb Bengaard, Eam Slijfer, CN Ghazarian, PD van der Linden, Schwap, LL Krens, M van Heuckelum, CM Maesano, Ljj Derijks, MT Tardella, I Cornelissen-Wesseling, DL Hilarius, Jdj Verdonk, EV Viegas, IC Carmo, P van Wijngaarden, AG Otten-Helmers, ZB Bisoffi, G M Martini, Janneke A L van Kempen, SC van Dijk, LC Hendriksen, M Maragna, Emp Platania, E Roobol-Meuwese, B Dilek, E Boemaars, FS Salaffi, Lph Portillo Horcajada, HF Farinha, Z Getrouw, Bob P A van de Loo, A Vos, Mbh Houlind, EE Roelofsen, Solano
Publikováno v:
The Lancet Healthy Longevity, 2(3), e163-e170. Elsevier Ltd.
The Lancet. Healthy Longevity
The Lancet Healthy Longevity, 2(3), e163-e170. Elsevier Ltd
The Lancet Healthy Longevity, 2(3), e163-e170. Lancet Publishing Group
The Lancet. Healthy Longevity, Vol 2, Iss 3, Pp e163-e170 (2021)
The Lancet Healthy Longevity
The Lancet Healthy Longevity, 2(3), E163-E170. ELSEVIER
The Lancet. Healthy Longevity
The Lancet Healthy Longevity, 2(3), e163-e170. Elsevier Ltd
The Lancet Healthy Longevity, 2(3), e163-e170. Lancet Publishing Group
The Lancet. Healthy Longevity, Vol 2, Iss 3, Pp e163-e170 (2021)
The Lancet Healthy Longevity
The Lancet Healthy Longevity, 2(3), E163-E170. ELSEVIER
Background: During the COVID-19 pandemic, the scarcity of resources has necessitated triage of critical care for patients with the disease. In patients aged 65 years and older, triage decisions are regularly based on degree of frailty measured by the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::62769c4e206f6c565ea3d2e7353bb31f
https://pure.eur.nl/en/publications/63631910-99ae-4894-bf51-70737137322d
https://pure.eur.nl/en/publications/63631910-99ae-4894-bf51-70737137322d
Autor:
Roos S G Sablerolles, MD, Melvin Lafeber, MD, Janneke A L van Kempen, MD, Bob P A van de Loo, Msc, Eric Boersma, ProfPhD, Wim J R Rietdijk, PhD, Harmke A Polinder-Bos, MD, Simon P Mooijaart, MD, Hugo van der Kuy, ProfPharmD, Jorie Versmissen, MD, Miriam C Faes, MD, LA Agnoletto, J Aleman, S Andreassi, LM Andrews, L Ashfield, H Bell, AKB Bengaard, SB Berlinghini, KB Bini, ZB Bisoffi, KB Blum, E Boemaars, GB Boni, TM Bosch, BE Bosma, F Boutkourt, C Bufarini, A Bulsink, RC Cabuk, GC Callens, MC Candela, MC Canonici, EC Capone, IC Carmo, FC Caruso, PC Chessa, GC Cohet, I Cornelissen-Wesseling, KML Crommentuijn, FM de Stoppelaar, HAJM de Wit, DS Deben, LJJ Derijks, MDC Di Carlo, J Diepstraten, B Dilek, DMK Duchek-Mann, MM Ebbens, LJ Ellerbroek, M Ezinga, MF Falcao, FF Falcao, LF Fantini, HF Farinha, PMG Filius, NJ Fitzhugh, G Fleming, TF Forsthuber, GG Gambarelli, MG Gambera, CGY García Yubero, Z Getrouw, CN Ghazarian, N Goodfellow, MQG Gorgas, RG Grinta, K Guda, DH Haider, J Hanley, KH Heitzeneder, WL Hemminga, LC Hendriksen, DL Hilarius, FEF Hogenhuis, IC Hoogendoorn-de Graaf, MBH Houlind, MAH Huebler, KPGM Hurkens, PKC Janssen, E Jong, MHW Kappers, KFM Keijzers, MK Kemogni, EM Kemper, RA Kranenburg, LL Krens, JL G Le Grand, J Liang, S Lim, NL Lindner, EL Loche, AL Lubich, B Maat, CM Maesano, AM Maiworm, M Maragna, FM Marchesini, IM Martignoni, G M Martini, CM Masini, R Mc Menamin, DM Mendes, M Miarons, R Moorlag, MR Müller, FN Nagele, KN Nemec, GO Oka, AG Otten-Helmers, SP Pagliarino, FP Pappalardo, M Patel, PM Peverini, FP Pieraccini, EMP Platania, NPK Pons-Kerjean, LPH Portillo Horcajada, GR Rametta, JR Rijo, EE Roelofsen, E Roobol-Meuwese, LR Rossi, SAH Russel, Z Safipour, FS Salaffi, L Saleh, AMS Schimizzi, JMGA Schols, MS Schwap, MG Scott, EAM Slijfer, EMA Slob, JS Soares, MS Solano, F Sombogaard, GS Stemer, MT Tardella, PGJ ter Horst, RT Tessari, J Tournoy, RB van den Berg, L Van der Linden, PD van der Linden, SC van Dijk, RW Van Etten, IMM van Haelst, M van Heuckelum, HJM van Kan, C van Nieuwkoop, HAW van Onzenoort, P van Wijngaarden, JDJ Verdonk, Fv Verri, JAMC Verstijnen, MV Veyrier, EV Viegas, LE Visser, A Vos, MAM Vromen, PC Wierenga, DR Wong, CZ Zenico, TZ Zuppini
Publikováno v:
The Lancet. Healthy Longevity, Vol 2, Iss 3, Pp e163-e170 (2021)
Summary: Background: During the COVID-19 pandemic, the scarcity of resources has necessitated triage of critical care for patients with the disease. In patients aged 65 years and older, triage decisions are regularly based on degree of frailty measur
Externí odkaz:
https://doaj.org/article/25542a489c0c438688fb4c4de1d44583